Ambee Pharmaceuticals PLC (DSE:AMBEEPHA)

Ambee Pharmaceuticals Revenue

Ambee Pharmaceuticals had revenue of 54.26M BDT in the quarter ending March 31, 2025, with 19.68% growth. This brings the company's revenue in the last twelve months to 235.22M, up 14.61% year-over-year. In the fiscal year ending June 30, 2024, Ambee Pharmaceuticals had annual revenue of 219.30M with 10.71% growth.

• Revenue (ttm): 235.22M
• Revenue Growth: +14.61%
• P/S Ratio: 8.33
• Revenue / Employee: 444.64K
• Employees: 529
• Market Cap: 1.96B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	219.30M	21.21M	10.71%
Jun 30, 2023	198.10M	17.10M	9.45%
Jun 30, 2022	180.99M	82.02M	82.86%
Jun 30, 2021	98.98M	-186.33M	-65.31%
Jun 30, 2020	285.30M	-35.92M	-11.18%